Rx-360 Takes Hold In India | Chemical & Engineering News
Volume 93 Issue 20 | p. 17 | Concentrates
Issue Date: May 18, 2015

Rx-360 Takes Hold In India

Department: Business
Keywords: heparin, China, India, supply chain, API, Hikal, active pharmaceutical ingredients

The pharmaceutical supply-chain safety group Rx-360 has set up a working group in India about two years after establishing itself in China. The working group is led by representatives from Eli Lilly & Co., Amgen, and the Indian fine chemicals producer Hikal. With headquarters in Washington, D.C., Rx-360 was established six years ago after tainted heparin from China led to the deaths of dozens of U.S. patients. Rx-360 members had earlier complained about difficulty in attracting interest from Indian firms.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment